Alnylam Pharmaceuticals | ALNY - 销售收入

金融业

USD 167.38

USD 7.99B

现金及等价物

USD 1.75B

USD 361.75M

USD 5.11B

USD 2.06B

USD 2.48B

USD 179.66M

USD 360.27M

2.23K

EPS每股收益

USD 16.26

股本和储备

USD 3.6B

USD 930.2M

债务利息支出

USD -84.37M

USD 28.14M

USD 2.11B

USD 21.89B

USD 2.17B

USD 1.11B

USD 179.66M

普通股股本

USD 133.88M

13.17

USD 295.81M

USD 1.46B

销售和管理费用

USD 342M

USD 105.91M

贸易债权人

USD 135.4M

应收帐款人

USD 1.08B

	销售	更改		日
Acadia Pharmaceuticals	USD 307.96M		39.9M	2026-06
Agios Pharmaceuticals	USD 44.74M		25.94M	2026-06
Alnylam Pharmaceuticals	USD 1.46B		170M	2026-09
Amgen	USD 10.1B		1.48B	2026-06
Arrowhead Research	USD 75.23M		1.49M	2026-06
BioCryst Pharmaceuticals	USD 218.25M		188.3M	2026-06
BioMarin Pharmaceutical	USD 990M		224M	2026-06
Incyte	USD 1.56B		110M	2026-09
Ionis Pharmaceuticals	USD 268M		22M	2026-06
Moderna	USD 100M		289M	2026-06
Neurocrine Biosciences	USD 959M		148M	2026-06
Novartis	USD 13.11B		750M	2026-03
PTC Therapeutics	USD 357.8M		3.2M	2026-09
Regeneron Pharmaceuticals	USD 5.12B		830M	2026-09
Sangamo BioSciences	USD 356K		125K	2024-06
Sanofi	EUR 12.14B		65M	2026-03
Sarepta Therapeutics	USD 401.3M		329.5M	2026-06
Takeda	JPY 1.19T		32.9B	2026-09
Tectonic Therapeutic	USD 0		0	2024-12
Ultragenyx Pharmaceutical	USD 214M		78M	2026-06
Vertex Pharmaceuticals	USD 3.33B		340M	2026-06
Xencor	USD 51.22M		46.71M	2026-06